Mouse Monoclonal Tristetraprolin/TTP antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Dog samples. Cited in 1 publication. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human ZFP36.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine), 1% BSA
IHC-P | WB | Flow Cyt (Intra) | |
---|---|---|---|
Human | Tested | Tested | Tested |
Mouse | Expected | Tested | Tested |
Dog | Expected | Tested | Expected |
Species | Dilution info | Notes |
---|---|---|
Species Human | Dilution info 1/150 | Notes Perform heat-mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol. |
Species | Dilution info | Notes |
---|---|---|
Species Mouse, Dog | Dilution info Use at an assay dependent concentration. | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/2000 | Notes - |
Species Human | Dilution info 1/2000 | Notes - |
Species Dog | Dilution info 1/2000 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1/100 | Notes - |
Species Human | Dilution info 1/100 | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Dog | Dilution info Use at an assay dependent concentration. | Notes - |
Select an associated product type
Zinc-finger RNA-binding protein that destabilizes several cytoplasmic AU-rich element (ARE)-containing mRNA transcripts by promoting their poly(A) tail removal or deadenylation, and hence provide a mechanism for attenuating protein synthesis (PubMed:10330172, PubMed:10751406, PubMed:11279239, PubMed:12115244, PubMed:12748283, PubMed:15187101, PubMed:15634918, PubMed:16702957, PubMed:17030620, PubMed:20221403, PubMed:20702587, PubMed:21775632, PubMed:23644599, PubMed:25815583, PubMed:27193233, PubMed:31439631, PubMed:9703499). Acts as an 3'-untranslated region (UTR) ARE mRNA-binding adapter protein to communicate signaling events to the mRNA decay machinery (PubMed:15687258, PubMed:23644599). Recruits deadenylase CNOT7 (and probably the CCR4-NOT complex) via association with CNOT1, and hence promotes ARE-mediated mRNA deadenylation (PubMed:23644599). Functions also by recruiting components of the cytoplasmic RNA decay machinery to the bound ARE-containing mRNAs (PubMed:11719186, PubMed:12748283, PubMed:15687258, PubMed:16364915). Self regulates by destabilizing its own mRNA (PubMed:15187101). Binds to 3'-UTR ARE of numerous mRNAs and of its own mRNA (PubMed:10330172, PubMed:10751406, PubMed:12115244, PubMed:15187101, PubMed:15634918, PubMed:16702957, PubMed:17030620, PubMed:19188452, PubMed:20221403, PubMed:20702587, PubMed:21775632, PubMed:25815583). Plays a role in anti-inflammatory responses; suppresses tumor necrosis factor (TNF)-alpha production by stimulating ARE-mediated TNF-alpha mRNA decay and several other inflammatory ARE-containing mRNAs in interferon (IFN)- and/or lipopolysaccharide (LPS)-induced macrophages (By similarity). Also plays a role in the regulation of dendritic cell maturation at the post-transcriptional level, and hence operates as part of a negative feedback loop to limit the inflammatory response (PubMed:18367721). Promotes ARE-mediated mRNA decay of hypoxia-inducible factor HIF1A mRNA during the response of endothelial cells to hypoxia (PubMed:21775632). Positively regulates early adipogenesis of preadipocytes by promoting ARE-mediated mRNA decay of immediate early genes (IEGs) (By similarity). Negatively regulates hematopoietic/erythroid cell differentiation by promoting ARE-mediated mRNA decay of the transcription factor STAT5B mRNA (PubMed:20702587). Plays a role in maintaining skeletal muscle satellite cell quiescence by promoting ARE-mediated mRNA decay of the myogenic determination factor MYOD1 mRNA (By similarity). Associates also with and regulates the expression of non-ARE-containing target mRNAs at the post-transcriptional level, such as MHC class I mRNAs (PubMed:18367721). Participates in association with argonaute RISC catalytic components in the ARE-mediated mRNA decay mechanism; assists microRNA (miRNA) targeting ARE-containing mRNAs (PubMed:15766526). May also play a role in the regulation of cytoplasmic mRNA decapping; enhances decapping of ARE-containing RNAs, in vitro (PubMed:16364915). Involved in the delivery of target ARE-mRNAs to processing bodies (PBs) (PubMed:17369404). In addition to its cytosolic mRNA-decay function, affects nuclear pre-mRNA processing (By similarity). Negatively regulates nuclear poly(A)-binding protein PABPN1-stimulated polyadenylation activity on ARE-containing pre-mRNA during LPS-stimulated macrophages (By similarity). Also involved in the regulation of stress granule (SG) and P-body (PB) formation and fusion (By similarity). Plays a role in the regulation of keratinocyte proliferation, differentiation and apoptosis (PubMed:27182009). Plays a role as a tumor suppressor by inhibiting cell proliferation in breast cancer cells (PubMed:26926077). (Microbial infection) Negatively regulates HTLV-1 TAX-dependent transactivation of viral long terminal repeat (LTR) promoter.
G0S24, NUP475, RNF162A, TIS11A, TTP, ZFP36, mRNA decay activator protein ZFP36, G0/G1 switch regulatory protein 24, Growth factor-inducible nuclear protein NUP475, Tristetraprolin, Zinc finger protein 36, Zfp-36
Mouse Monoclonal Tristetraprolin/TTP antibody. Suitable for IHC-P, WB, Flow Cyt (Intra) and reacts with Human, Mouse, Dog samples. Cited in 1 publication. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human ZFP36.
pH: 7.3
Preservative: 0.02% Sodium azide
Constituents: PBS, 50% Glycerol (glycerin, glycerine), 1% BSA
Purified from cell culture supernatant by affinity chromatography.
Clone OTI1A2 (formerly 1A2).
Abcam is leading the way to address reproducibility in scientific research with our highly validated recombinant monoclonal and recombinant multiclonal antibodies. Search & select one of Abcam's thousands of recombinant alternatives to eliminate batch-variability and unnecessary animal use.
If you do not find a host species to meet your needs, our catalogue and custom Chimeric range provides scientists the specificity of Abcam's RabMAbs in the species backbone of your choice. Remember to also review our range of edited cell lines, proteins and biochemicals relevant to your target that may help you further your research goals.
Abcam antibodies are extensively validated in a wide range of species and applications, so please check the reagent specifications meet your scientific needs before purchasing. If you have any questions or bespoke requirements, simply visit the Contact Us page to send us an inquiry or contact our Support Team ahead of purchase.
Tristetraprolin (TTP) also called ZFP36 is a protein that regulates mRNA stability and decay. It has a molecular mass of approximately 36 kDa. TTP usually resides in the cytoplasm and nucleus of a cell. Many types of tissues especially those involved in immune response express TTP. Researchers have identified TTP as part of a family of CCCH zinc-finger proteins which play key roles in mRNA turnover by binding to AU-rich elements in the 3' untranslated regions of target mRNAs.
TTP controls the degradation of cytokine mRNAs such as TNF-alpha and GM-CSF by inducing deadenylation and subsequent decay. As part of mRNA degradation complexes TTP recruits enzymes that participate in the deadenylation process ensuring precise regulation of gene expression. This ability to selectively regulate mRNA levels helps balance the production of proteins important for inflammation immune responses and cell growth. Through these processes TTP maintains cellular homeostasis and modulates responses to environmental changes.
TTP functions within the anti-inflammatory pathway by modulating cytokine levels and the NF-kappaB signaling pathway which are important for cellular stress responses and immune regulation. It affects these pathways by interacting with several proteins including 14-3-3 that regulate its activity and localization. Another key interaction is with deadenylase complexes like CAF1 which are integral in carrying out mRNA decay. These interactions allow TTP to effectively manage inflammatory responses reinforcing its regulatory role in immune system pathways.
Altered TTP expression or function links to autoimmune diseases and certain cancers. In autoimmune conditions like rheumatoid arthritis reduced TTP levels are associated with an overproduction of inflammatory cytokines. This imbalance leads to chronic inflammation and tissue damage. In cancers especially breast cancer TTP downregulation can contribute to tumor progression by allowing increased expression of mRNAs involved in cell proliferation and survival. Other proteins such as TNF-alpha and IL-6 have been observed to interact closely with TTP in these disease contexts.
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-Tristetraprolin/TTP antibody [OTI1A2] (ab119779) at 1/200 dilution
Lane 1: SVT2 cell extract at 10 µg
Lane 2: A549 (human lung carcinoma cell line) cell extract at 10 µg
Lane 3: MDCK (canine kidney cell line) cell extract at 10 µg
Predicted band size: 34 kDa
Flow cytometric analysis of HeLa (human epithelial cell line from cervix adenocarcinoma) cell line labeling Tristetraprolin/TTP with ab119779 at 1/100 dilution (red) compared to a nonspecific negative control antibody (blue).
All lanes: Western blot - Anti-Tristetraprolin/TTP antibody [OTI1A2] (ab119779) at 1/200 dilution
All lanes: Mouse liver extract at 10 µg
Predicted band size: 34 kDa
All lanes: Western blot - Anti-Tristetraprolin/TTP antibody [OTI1A2] (ab119779) at 1/2000 dilution
Lane 1: HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen) cell lysate transfected with pCMV6-ENTRY control cDNA at 5 µg
Lane 2: HEK-293T cell lysate transfected with pCMV6-ENTRY Tristetraprolin/TTP cDNA at 5 µg
Predicted band size: 34 kDa
Flow cytometric analysis of Jurkat (human T cell leukemia cell line from peripheral blood) cell line labeling Tristetraprolin/TTP with ab119779 at 1/100 dilution (red) compared to a nonspecific negative control antibody (blue).
Paraffin-embedded human bladder carcinoma tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Paraffin-embedded human breast tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Paraffin-embedded human endometrium tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Paraffin-embedded human endometrium adenocarcinoma tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Paraffin-embedded human lung carcinoma tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Paraffin-embedded human pancreas carcinoma tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Paraffin-embedded human tonsil tissue stained for Tristetraprolin/TTP using ab119779 at 1/150 dilution in immunohistochemical analysis.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com